The results indicate that the enhanced inhibition of tumor cell growth by melatonin might be also mediated partially via the p50/p65 NF-κB/COX-2 signaling pathway in NSCLC cells. This evidence concerns the gene PTGS2 and non-small cell lung carcinoma.